Skip to content

Higher tumor stemness was linked to poorer survival in oral cancer

Molecular scores and tissue markers were associated with overall survival, without establishing that targeting these features would improve treatment outcomes.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review asked whether tumor stemness, measured through molecular signatures or tissue markers associated with cancer stem cells, predicts survival in oral cancer. Higher molecular scores and positive tissue-marker profiles were linked to poorer overall survival. These associations support further research on prognosis but do not show that changing the markers improves survival.

Keep in mind

The main tissue-marker analysis relied on 2 studies. An exploratory analysis mixing survival time horizons was inconclusive. Abstract-only access cannot establish how accurately these markers predict an individual patient's outcome.

THE NUMBERS, WITH CONTEXT

What researchers found

Hazard ratio 2.24 (95% CI 1.61-3.12)

Overall survival with higher computational stemness

Estimated death rate among people still alive at a given time: 2.24 times as high with higher versus lower scores. Follow-up duration was not reported; this is not an absolute death probability.

Med Sci (Basel), 2025 · Original source ↓

How stemness was measured

Computational scores drew on patterns in gene activity or epigenetic data. Tissue staining identified cancer stem cell profiles. The review analyzed these approaches separately, so its results do not make them interchangeable tests.

What survival associations show

The main outcome was overall survival. A link between tumor features and survival can suggest a prognostic marker, but it does not demonstrate that the feature causes death or that targeting it helps patients.

CHECK THE ORIGINAL

The original publication

Computational Stemness and Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma: A Systematic Review, Dual Meta-Analysis, and Functional Meta-Synthesis.

Ardila CM, Pineda-Vélez E, Vivares-Builes AM
Med Sci (Basel) · 2025

PubMed ID
41562911
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.